AAAAAA
Results:
1-20
|
Results: 20
Authors:
Funfsinn, N
Caliezi, C
Biasiutti, FD
Korte, W
Z'Brun, A
Baumgartner, I
Ulrich, M
Cottier, C
Lammle, B
Wuillemin, WA
Citation: N. Funfsinn et al., Rapid D-dimer testing and pre-test clinical probability in the exclusion of deep venous thrombosis in symptomatic outpatients, BL COAG FIB, 12(3), 2001, pp. 165-170
Authors:
Redondo, M
Carroll, VA
Mauron, T
Biasiutti, FD
Binder, BR
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events, BL COAG FIB, 12(1), 2001, pp. 17-24
Authors:
Fiorante, P
Banz, Y
Mohacsi, PJ
Kappeler, A
Wuillemin, WA
Macchiarini, P
Roos, A
Daha, MR
Schaffner, T
Haeberli, A
Mazmanian, GM
Rieben, R
Citation: P. Fiorante et al., Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models, XENOTRANSPL, 8(1), 2001, pp. 24-35
Authors:
Oldenburg, J
Kriz, K
Wuillemin, WA
Maly, FE
von Felten, A
Siegemund, A
Keeling, DM
Baker, P
Chu, K
Konkle, BA
Lammle, B
Albert, T
Citation: J. Oldenburg et al., Genetic predisposition to bleeding during oral anticoagulant therapy: Evidence for common founder mutations (FIXVal-10 and FIXThr-10) and an independent CpG hotspot mutation (FIXThr-10), THROMB HAEM, 85(3), 2001, pp. 454-457
Authors:
Wuillemin, WA
Biasiutti, FD
Mattle, HP
Lammle, B
Citation: Wa. Wuillemin et al., Frequency of protein Z deficiency in patients with ischaemic stroke, LANCET, 358(9284), 2001, pp. 840-840
Authors:
Redondo, M
Caliezi, C
Biasiutti, FD
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation, ATHEROSCLER, 157(2), 2001, pp. 417-422
Authors:
Kobelt, K
Biasiutti, FD
Mattle, HP
Lammle, B
Wuillemin, WA
Citation: K. Kobelt et al., Protein Z in ischaemic stroke, BR J HAEM, 114(1), 2001, pp. 169-173
Authors:
Zeerleder, S
Hack, CE
Caliezi, C
Hebeisen, R
Wuillemin, WA
Citation: S. Zeerleder et al., Bacillus Calmette-Guerin sepsis: shift of an intended local toward a detrimental systemic cytotoxic immune response, BLOOD, 98(3), 2001, pp. 890-891
Authors:
Moshfegh, K
Redondo, M
Julmy, F
Wuillemin, WA
Gebauer, MU
Haeberli, A
Meyer, BJ
Citation: K. Moshfegh et al., Antiplatelet effects of clopidogrel compared with aspirin after myocardialinfarction: Enhanced inhibitory effects of combination therapy, J AM COL C, 36(3), 2000, pp. 699-705
Authors:
Mauron, T
Lammle, B
Wuillemin, WA
Citation: T. Mauron et al., High molecular weight kininogen is cleaved by FXIa at three sites: Arg(409)-Arg(410), Lys(502)-Thr(503) and Lys(325)-Lys(326), THROMB HAEM, 83(5), 2000, pp. 709-714
Authors:
Caliezi, C
Reber, G
Lammle, B
de Moerloose, P
Wuillemin, WA
Citation: C. Caliezi et al., Agreement of D-dimer results measured by a rapid ELISA (VIDAS) before and after storage during 24 h or transportation of the original whole blood samples, THROMB HAEM, 83(1), 2000, pp. 177-178
Authors:
Caliezi, C
Waber, M
Pfiffner, D
Saner, H
Lammle, B
Wuillemin, WA
Citation: C. Caliezi et al., Patient self-control of oral anticoagulation with CoaguChek (R), SCHW MED WO, 130(24), 2000, pp. 916-923
Authors:
Chiappini, D
Wuillemin, WA
Gardi, M
Jeanneret, C
Tobler, A
Citation: D. Chiappini et al., Comparability of haematology profile between QBC (R) Autoread (TM) Plus System and all electronic cell counting instrument (Coulter Counter STKS), SCHW MED WO, 130(15), 2000, pp. 545-550
Authors:
Caliezi, C
Wuillemin, WA
Zeerleder, S
Redondo, M
Eisele, B
Hack, CE
Citation: C. Caliezi et al., C1-esterase inhibitor: An anti-inflammatory agent and its potential use inthe treatment of diseases other than hereditary angioedema, PHARM REV, 52(1), 2000, pp. 91-112
Authors:
Redondo, M
Watzke, HH
Stucki, B
Sulzer, I
Biasiutti, FD
Binder, BR
Furlan, M
Lammle, B
Wuillemin, WA
Citation: M. Redondo et al., Coagulation factors II, V, VII, and X, prothrombin gene 20210G -> A transition, and factor V Leiden in coronary artery disease - High factor V clotting activity is an independent risk factor for myocardial infarction, ART THROM V, 19(4), 1999, pp. 1020-1025
Authors:
Zeerleder, S
Schloesser, M
Redondo, M
Wuillemin, WA
Engel, W
Furlan, M
Lammle, B
Citation: S. Zeerleder et al., Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - A study on 73 subjects from 14 Swiss families, THROMB HAEM, 82(4), 1999, pp. 1240-1246
Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients
Authors:
Caliezi, C
Funfsinn, N
Mauron, T
Baumgartner, I
Sulzer, I
Ulrich, M
Cottier, C
Biasiutti, FD
Lammle, B
Wuillemin, WA
Citation: C. Caliezi et al., Performance of a new fibrin monomer assay to exclude deep vein thrombosis in symptomatic outpatients, THROMB HAEM, 81(1), 1999, pp. 50-53
Authors:
Wuillemin, WA
Solenthaler, M
Citation: Wa. Wuillemin et M. Solenthaler, Hyperhomocysteinemia and thrombotic vascular disease, VASA, 28(3), 1999, pp. 151-155
Authors:
Moshfegh, K
Wuillemin, WA
Redondo, M
Lammle, B
Beer, JH
Liechti-Gallati, S
Meyer, BJ
Citation: K. Moshfegh et al., Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study, LANCET, 353(9150), 1999, pp. 351-354
Authors:
Zeerleder, S
Caliezi, C
Redondo, M
Devay, J
Wuillemin, WA
Citation: S. Zeerleder et al., Activation of the plasmatic cascade systems in sepsis: role of C1-inhibitor, SCHW MED WO, 129(39), 1999, pp. 1410-1417
Risultati:
1-20
|